
Consuelo Walss-Bass
Consuelo Walss-Bass, PhD, professor of Psychiatry and Behavioral Sciences, focuses her research on understanding of psychiatric disorders at the molecular level. She utilizes genomic and proteomic approaches in human and animal models to correlate genetic/epigenetic modifications with cellular function and brain in order to understand the mechanisms that are involved in development and expression of mental illnesses and behavior.
Walss-Bass established the UTHealth Brain Collection resource to help study brain disorders and create healthy changes for future generations. Brain tissue provides a crucial resource for understanding the biological causes of mental illness and other psychological challenges, such as substance abuse. In addition, she is currently studying the development of human induced-pluripotent stem cells and subsequent differentiation into neuronal cells and astrocytes to obtain virtual brain biopsies of individuals with psychiatric disorders.
Walss-Bass also leads the Psychiatric Genetics Program, in which she assists clinical investigators in genotype-phenotype correlations to better understand the genetic underpinnings of psychiatric disorders. Her other research interests include gene-environment interactions, correlation of genetic variants with cellular function and antipsychotic-induced metabolic syndrome.
Education
Doctoral Degree
Biochemistry, University of Texas Health Science Center at San Antonio
Postdoctoral Fellowship
Genetics, University of Texas Health Science Center at San Antonio
Publications
- Functional Genomics Studies of Psychiatric Disorders in Individuals of Latin American Populations: A Scoping Review
- Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group
- Identifying bio-behavioural signatures of persistent opioid use risk in trauma injury patients: a protocol for a prospective cohort study
- Blood and neuronal extracellular vesicle mitochondrial disruptions in schizophrenia
- Lipidomic and proteomic insights from extracellular vesicles in the postmortem dorsolateral prefrontal cortex reveal substance use disorder-induced brain changes